INDIVIDUALIZATION OF CANCER TREATMENT: CONTRIBUTION OF OMICS TECHNOLOGIES TO CANCER DIAGNOSTIC
Journal: Biotechnologia Acta (Vol.6, No. 4)Publication Date: 2013-08-30
Authors : S. Souchelnytskyi;
Page : 105-117
Keywords : personalized cancer medicine; genomics; transcriptomics; proteomics; metabolomics; diagnostic.;
Abstract
Cancer is a disease, which explicitly illustrates success, failures and challenges of the modern biomedical research. Technology development has been the driving force of improvements in the cancer treatment. Introduction into clinical practice of genomics, RNA profiling and proteomics technologies have provided a basis for development of novel diagnostic, drugs and treatments. In this chapter, contributions of OMICs technologies to personalization of cancer diagnostic and treatment are discussed. The focus is on technologies that showed capacity to deliver diagnostic that may be used in the clinic as routine tests. Three clinical cases are presented to illustrate already available individualized cancer diagnostic.
Other Latest Articles
- PLANT TISSUE CULTURE IN BIOTECHNOLOGY: RECENT ADVANCES IN TRANSFORMATION THROUGH SOMATIC EMBRYOGENESIS
- DEGRADATION OF ANTHROPOGENIC CONTAMINANTS BY HIGHER PLANTS
- POLYADHESINS: AN ARMORY OF GRAM--NEGATIVE PATHOGENS FOR PENETRATION THROUGH THE IMMUNE SHIELD
- THE GMP-BASED DRUG SUBSTANCE SCTL DEVELOPMENT AIMING AT PREVENTION OF OPPORTUNISTIC INFECTIONS AFTER X-RAY- AND CHEMOTHERAPY OF CANCER. A SYNTHETIC COMBINATORIAL TETRAPEPTIDE LIBRARY SUBSTITUTION FOR CALF THYMUS EXTRACT
- THE VITAL IMPORTANCE OF PROVIDING SOUND SCIENTIFIC ADVICE TO POLICY MAKERS IN GOVERNMENT
Last modified: 2016-11-19 01:37:38